ClinicalTrials.gg
CompletedNCT02753361Updated Oct 19, 2017

Ultra-sounded Guided Regional Blockade for Lipoma Excision

An interventional study of Ultrasound guidance in Lipomas, sponsored by Suez Canal University. Completed at 1 site in Egypt. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2017-10-19.

Sponsored by Suez Canal University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

There is limited information on using the ultrasonography for block placement concerning lipoma excision. A new type of regional blockade, performed under ultrasound, can ensure proper block placement with accurate local anesthetics deposition. Investigators hypothesized that ultrasound guidance can reduce the number of needle passes to complete the block placement. Investigators will compare namely ultrasound guided regional blockade and traditional method regarding the number of needle passes to complete the block placement.

Read the detailed description

50 patients between the ages of 18 and 60 years with American Society of Anesthesiologists (ASA) physical status I-III, scheduled for superficial subcutaneous lipoma (sized from 5 to 7 cm) excision will be enrolled in prospective comparative randomized clinical study.

Patients will be randomized into two groups: U (n = 25), in whom regional blockade was performed using US-guidance; and C (n = 25), in whom regional block was performed using the traditional method. Patients will be randomly assigned on a one-to-one ratio. Randomization will be performed by means of a computer generated random-numbers table. Group allocation will be concealed in sealed opaque envelopes that will not opened until patient consent had been obtained.

All patients will be pre-medicated with oral diazepam (7.5 mg) 30 min before the procedure, and IV fentanyl (50 ug) will be administered 5 minutes before placement of the block. Before the procedure, an IV access and standard monitoring of electrocardiogram (ECG), noninvasive blood pressure (NIBP), and peripheral oxygen saturation (SPO2) will be established.

Primary outcome includes the number of needle attempts (number of skin punctures and needle redirections) needed to complete the block placement. It will be documented by an investigator blinded to the aim of the study. Patient demographics, duration of surgery, patient's ASA physical status and other study outcomes will be documented by independent investigators who were not involved in the block placement procedure and were blinded to the group assignment.

02

Conditions studied

  • Lipomas

Browse trials for

Keywords

  • Ultrasound
  • regional blockade
  • lipoma
03

In context

Lipoma

22 studies on the registry are indexed under Lipoma; 6 are open to participants now.

This study's enrollment of 50 is above the median of 30 across 17 interventional studies indexed under Lipoma.

Browse Lipoma studies →

Lead sponsor

Suez Canal University is the lead sponsor of 164 studies on the registry; 38 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients between the ages of 18 and 60 years
  • (ASA) physical status I-III
  • Superficial subcutaneous lipoma excision surgery (sized from 5 to 7 cm)
  • Able to provide
  • Consent to participates
  • Single procedure

Exclusion criteria

Exclusion Criteria:

  • Unable to consent
  • Do not consent to participate
  • Patients with local infections in the skin over lipoma
  • Patients with history of allergy to local anesthetics
  • More than one procedure is being performed at the same setting
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
50 participants (actual)

Study arms

  • No intervention
    Traditional

    This will utilize the traditional method of performance of regional block

  • Experimental
    US-guided

    In this arm, regional block will be performed under the ultrasound guidance

    Procedure: Ultrasound guidance

Interventions

  • ProcedureUltrasound guidance

    In the second arm, ultrasound will be used to guide the regional block

06

What researchers measure

Primary outcomes

  1. The number of needle attempts needed to complete the block placement. New attempt will be defined as needle reinsertions through separate skin puncture.

    Time frame: 10 - 20 minutes

Secondary outcomes

  1. The block success rate

    The block success rate is assessed according to the adequacy of surgical anesthesia and is defined as complete loss of sensation to pinprick within 20 min of anesthetic administration and if no supplementation (sedative or analgesic) is required during surgery.Partial block is defined as inadequate sensory blockade after 20 min of anesthetic administration. The supplementation (additional LA infiltration or IV analgesic; fentanyl) is required to complete the proposed surgery. Failed block is considered if general anesthesia is required to complete the proposed surgery.

    Time frame: 20 minutes

  2. The incidence of adverse events

    Time frame: 8 hours postoperatively

07

Study locations

1 site
  • Suez canal University hospital
    Ismailia, 41111, Egypt
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 19, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02753361
Responsible party
Tarek F.Tammam (Tarek F.Tammam, M.D., Ph.D, Department of Anesthesia and Intensive Care, Faculty of Medicine, Suez Canal University Hospital, Egypt, Suez Canal University) — Principal investigator
First posted
Apr 27, 2016
Start date
May 2016
Primary completion
Nov 16, 2016
Completion
Dec 7, 2016
Last update
Oct 19, 2017

Study contacts

Tarek F. Tammam, Prof.
study director · Suez Canal university,Faculty of Medicine

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion